Why is BIVI Down Today?

BIVI
$1.20
▼ -4.76% ($-0.06)
Last updated: Nov 12, 2026 8:30 PM ET (90 min ago)

About BioVie, Inc. Common Stock

BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlle...

Sector: PHARMACEUTICAL PREPARATIONS
Market Cap: $14.99M
Forward P/E: -0.1
52-Week Range: $0.82 - $3.79
Employees: 13

Overall Confidence: 60%

60% Confident

Based on news, social sentiment, options activity, and sector analysis

SYMPATHY 60% Confidence
🎯 Outperforming sector by 4.2%
This stock is significantly underperforming its PHARMACEUTICAL PREPARATIONS sector peers, suggesting a stock-specific catalyst.

✅ Move Confirmation

LOW VOLUME 0.1x average volume

UNCONFIRMED - Low volume suggests this move may not be sustainable.

📍 Sector Context

PHARMACEUTICAL PREPARATIONS sector: -0.6%

BIVI is outperforming its sector by -4.2%. This suggests a stock-specific catalyst.

Market Comparison

BIVI is significantly underperforming the market (-4.4% vs SPY)
S&P 500
SPY
-0.35%
Nasdaq 100
QQQ
-0.32%
BIVI
This Stock
-4.76%
vs S&P 500: -4.41%
vs Nasdaq: -4.44%

📊 What Happens Next?

Probability Analysis

45% chance this move continues in the next 1-3 days

Expected Range

Based on historical patterns and options pricing, BIVI is expected to trade between:
$1.16 - $1.22

Key Level to Watch

$1.14 support
Watch for breakdown below $1.20

🔔 Get BIVI Alerts

We'll notify you when BIVI's trend changes or a new signal fires.

Last updated: Nov 12, 2026 8:30 PM (90 minutes ago)
Data refreshes every 30 minutes during market hours

Historical Context

BIVI has moved more than 3.0% down on 62 occasions in the past year.

40.3%
Continuation Rate
25/62 times continued down
+1.42%
Avg Next Day Change
After similar down moves
Last similar move: Nov 05, 2026 (-9.7%) → Next day: +9.9%

Frequently Asked Questions

Why is BIVI stock down today?

This stock is significantly underperforming its PHARMACEUTICAL PREPARATIONS sector peers, suggesting a stock-specific catalyst.

Is BIVI stock a buy or sell right now?

Based on current analysis, BIVI shows 60% confidence in today's move. Volume is low which does not confirm the trend. View full buy/sell analysis →

What is the BIVI stock price target?

BIVI is currently trading at $1.20. Based on today's momentum, the expected short-term range is $1.16 - $1.22. See long-term price prediction →

Will BIVI stock continue falling?

Our analysis shows a 45% probability that BIVI's move continues in the next 1-3 days. Key level to watch: $1.14 (support).

Is BIVI stock oversold or overbought?

BIVI's RSI (Relative Strength Index) is currently at 42.5. This shows bearish momentum - the stock has negative momentum but isn't oversold yet.

What is the momentum for BIVI stock?

BIVI's 10-day momentum indicator is at -0.19. Negative momentum - the stock has mild downward pressure which may continue short-term.

Is BIVI outperforming or underperforming the market?

BIVI (-4.76%) is currently significantly underperforming the market (-4.4% vs SPY). Today, the S&P 500 (SPY) is down -0.35%, and Nasdaq (QQQ) is down -0.32%.

What does MACD indicate for BIVI?

BIVI's MACD (-0.05) is currently below the signal line (-0.04), indicating a bearish trend. This technical signal suggests selling pressure is dominant. The trend strength (ADX: 26.3) is strong.

Is BIVI in an uptrend or downtrend?

Based on moving average analysis, BIVI is in a bearish trend. The price ($1.20) is trading below both the 20-day SMA ($1.33) and 50-day SMA ($1.5). This alignment typically indicates sustained downward pressure.

Check Why Another Stock is Moving

Enter any ticker symbol to see real-time analysis

Popular: AAPL TSLA NVDA MSFT META AMZN GOOGL